Buprenorfine/Naloxon Aurobindo 2 mg/0,5 mg, tabletten voor sublinguaal gebruik

{
  "form": "Tablet voor sublinguaal gebruik",
  "route": "Sublinguaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h121932_smpc.pdf",
  "strength": null,
  "atc_label": "Buprenorphine, Combinations",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg121932",
  "excipients": [
    "ACESULFAAM KALIUM (E 950)",
    "CITROENSMAAKSTOF",
    "CITROENZUUR 1-WATER (E 330)",
    "LACTOSE 1-WATER",
    "LIMOENSMAAKSTOF",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MALTODEXTRINE",
    "MALTODEXTRINE",
    "MANNITOL (D-) (E 421)",
    "MAÏSZETMEEL",
    "POVIDON K 30 (E 1201)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)"
  ],
  "substances": [
    "BUPRENORFINEHYDROCHLORIDE",
    "NALOXONHYDROCHLORIDE 2-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h121932.pdf",
  "authorised_at": "2018/10/19",
  "procedure_number": "PT/H/1918/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "121932",
  "additional_monitoring": "N"
}